Intellectual Property India Publishes Patent Application for 'Hexacyclic Topoisomerase Inhibitors Having Cytotoxic Activity On Cancer Cells' Filed by Nj Bio, Inc.

MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517007906 A) filed by Nj Bio, Inc., Princeton, U.S.A., on Jan. 30, for 'hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells.'

Inventor(s) include Jain, Nareshkumar; Prior, Allan; Murkli, Steven; Panth, Nabin; and Bhujade, Arti.

The application for the patent was published on April 11, under issue no. 15/2025.

According to the abstract released by the Intellectual Property India: "Disclosed are topoisomerase inhibitor compounds as cytotoxic agents and further as payloads for antibody-drug conjugates. Also disclosed are methods of making and use of the compounds in the treatment of proliferative diseases."

The patent app...